153 related articles for article (PubMed ID: 12557178)
21. Hepatitis B virus resistance to antivirals: clinical implications and management.
Zoulim F
J Hepatol; 2003; 39 Suppl 1():S133-8. PubMed ID: 14708691
[No Abstract] [Full Text] [Related]
22. Successful long-term control with lamivudine against reactivated hepatitis B infection following intensive chemotherapy and autologous peripheral blood stem cell transplantation in non-Hodgkin's lymphoma: experience of 2 cases.
Nakagawa M; Simizu Y; Suemura M; Sato B
Am J Hematol; 2002 May; 70(1):60-3. PubMed ID: 11994984
[TBL] [Abstract][Full Text] [Related]
23. [Lamivudine resistance impedes hepatitis B therapy].
Eggers HJ
Fortschr Med; 1997 Apr; 115(12):5. PubMed ID: 9235306
[No Abstract] [Full Text] [Related]
24. [Current treatment of hepatitis B].
Suárez García E; Romero Gómez M; Grande Santamaría L
Gastroenterol Hepatol; 2001 Feb; 24 Suppl 1():35-50. PubMed ID: 11279893
[No Abstract] [Full Text] [Related]
25. Adefovir dipivoxil to prevent exacerbation of lamivudine-resistant hepatitis B infection during chemotherapy for non-Hodgkin's lymphoma.
Enomoto M; Nishiguchi S; Seki S; Yamane T; Hino M
Am J Gastroenterol; 2004 Aug; 99(8):1619-20. PubMed ID: 15307884
[No Abstract] [Full Text] [Related]
26. [Effective treatment with Lamivudine of patients with reactivation of hepatitis B following chemotherapy administration].
Shtalrid M; Haran M; Klepfish A; Lurie Y; Malnick S
Harefuah; 2001 Dec; 140(12):1159-62, 1230, 1229. PubMed ID: 11789300
[TBL] [Abstract][Full Text] [Related]
27. Lamivudine for the prevention of hepatitis B virus reactivation during autologous stem cell transplantation. A case report.
Silvestri F; Sperotto A; Ermacora A; Fanin R; Damiani D; Baccarani M
Haematologica; 2000 Mar; 85(3):327-9. PubMed ID: 10702831
[No Abstract] [Full Text] [Related]
28. Controversies about the treatment of hepatitis B (lamivudine, interferon, a combination or more?).
Desai HG; Chowdhury A
Trop Gastroenterol; 2003; 24(3):157-60. PubMed ID: 14978995
[No Abstract] [Full Text] [Related]
29. [Treatment of liver cirrhosis due to hepatitis B with lamivudine].
Castellano G; Fernández I; Jiménez C; Solís Herruzo JA
Gastroenterol Hepatol; 1999 Oct; 22(8):433-4. PubMed ID: 10592680
[No Abstract] [Full Text] [Related]
30. Tenofovir helps experienced patients.
AIDS Patient Care STDS; 2002 Mar; 16(3):136. PubMed ID: 11951839
[No Abstract] [Full Text] [Related]
31. More uses for tenofovir?
AIDS Treat News; 2001 Jan; (377):4. PubMed ID: 11862808
[No Abstract] [Full Text] [Related]
32. Use of tenofovir.
AIDS Patient Care STDS; 2002 Jan; 16(1):52. PubMed ID: 11892609
[No Abstract] [Full Text] [Related]
33. Food and Drug Administration approves lamivudine for hepatitis B.
Front Med Biol Eng; 1999; 9(1):95. PubMed ID: 10354913
[No Abstract] [Full Text] [Related]
34. Treatment of chronic hepatitis B virus infection in patients co-infected with human immunodeficiency virus.
Benhamou Y; Poynard T
J Hepatol; 2003; 39 Suppl 1():S194-9. PubMed ID: 14708703
[No Abstract] [Full Text] [Related]
35. New strategies for treating AIDS.
Sandstrom PA; Folks TM
Bioessays; 1996 May; 18(5):343-6. PubMed ID: 8639156
[TBL] [Abstract][Full Text] [Related]
36. FDA approves tenofovir.
AIDS Patient Care STDS; 2002 Jan; 16(1):52. PubMed ID: 11892608
[No Abstract] [Full Text] [Related]
37. Promising results for tenofovir.
AIDS Patient Care STDS; 2000 Jul; 14(7):396. PubMed ID: 10935058
[No Abstract] [Full Text] [Related]
38. Rescue therapy for drug resistant hepatitis B: another argument for combination chemotherapy?
Shaw T; Bowden S; Locarnini S
Gastroenterology; 2004 Jan; 126(1):343-7. PubMed ID: 14699512
[No Abstract] [Full Text] [Related]
39. Tenofovir DF trial announced by Gilead.
Eagan L
Posit Living; 2000 Jul; 9(6):22, 54. PubMed ID: 12492018
[No Abstract] [Full Text] [Related]
40. Lamivudine therapy in renal allograft recipients with hepatitis B virus infection.
Tsang WK; Tong KL; Chan HW
Transplant Proc; 2003 Feb; 35(1):278-9. PubMed ID: 12591398
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
